CVRx, Inc.

NasdaqGS:CVRX

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

🏥 Hospitals & Clinics

🩺 Medical Instruments

💻 Telehealth

Location

United States

Market Cap

USD 151.74 M

Share Price

USD 5.82

Avg Daily Volume

421,031

Change (1 day)

-0.85%

Change (1 year)

-50.26%

Change (YTD)

-54.06%

CVRx, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2025: USD 52.87 M

CVRx, Inc. Revenue is USD 52.87 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 25.62% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

CVRx, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 42.09 M, a 59.59% change year over year.
CVRx, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 26.37 M, a 85.04% change year over year.
CVRx, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 14.25 M, a 98.08% change year over year.
CVRx, Inc. Revenue for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 7.20 M.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

NasdaqGS: CVRX

CVRx, Inc.

CEO	Mr. Kevin Hykes
IPO Date	June 30, 2021
Location	United States
Headquarters	9201 West Broadway Avenue
Employees	206
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 🏥 Hospitals & Clinics 🩺 Medical Instruments 💻 Telehealth

Description

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.